JIP
CAH icon

Jaffetilchin Investment Partners’s Cardinal Health CAH Stock Holding History

Jaffetilchin Investment Partners’s Portfolio CAH Stock Details CAH Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2022
Q4 		– Sell
-6,906
Closed -$461K – 348
2022
Q3 		$461K Buy
6,906
+495
+8% +$31.4K 0.06% 187
2022
Q2 		$335K Buy
+6,411
New +$364K 0.04% 239
2016
Q4 		– Sell
-4,303
Closed -$334K – 251
2016
Q3 		$334K Sell
4,303
-651
-13% -$52.6K 0.11% 142
2016
Q2 		$386K Buy
4,954
+297
+6% +$23.7K 0.12% 134
2016
Q1 		$382K Sell
4,657
-3,967
-46% -$323K 0.12% 108
2015
Q4 		$770K Buy
8,624
+4,745
+122% +$403K 0.25% 59
2015
Q3 		$298K Sell
3,879
-545
-12% -$45.5K 0.11% 146
2015
Q2 		$370K Sell
4,424
-3,891
-47% -$344K 0.11% 142
2015
Q1 		$751K Buy
8,315
+4,029
+94% +$347K 0.23% 73
2014
Q4 		$346K Buy
+4,286
New +$338K 0.12% 136
2014
Q1 		– Sell
-3,286
Closed -$220K – 193
2013
Q4 		$220K Buy
+3,286
New +$201K 0.11% 162

Other funds holding CAH

Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
Fidelity Investments
Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return
T. Rowe Price Associates
T. Rowe Price Associates Baltimore, Maryland $865B AUM 30.76% 1-Year Est. Return
Invesco
Invesco Atlanta, Georgia $1.02T AUM 30.18% 1-Year Est. Return
Morgan Stanley
Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return
Amundi
Amundi Paris, France $367B AUM 31.23% 1-Year Est. Return
Arrowstreet Capital
Arrowstreet Capital Boston, Massachusetts $185B AUM 39.58% 1-Year Est. Return

Jaffetilchin Investment Partners's CAH Position: Q4 2022 in Review

Jaffetilchin Investment Partners sold out of Cardinal Health (CAH) in Q4 2022, closing a stake of 6,906 shares — an estimated $461K sold.

Jaffetilchin Investment Partners first reported a position in CAH in Q4 2013 and held it in 11 quarters. The position peaked at $770K in Q4 2015. 931 funds tracked by Wall St. Rank hold CAH as of Q4 2022.

  • Jaffetilchin Investment Partners reported no remaining Cardinal Health position as of Q4 2022 after selling out during the quarter.
  • Jaffetilchin Investment Partners sold 6,906 Cardinal Health shares in Q4 2022, an estimated $461K.
  • Jaffetilchin Investment Partners first reported a position in Cardinal Health in Q4 2013 and held it in 11 quarters.
  • Jaffetilchin Investment Partners's Cardinal Health position peaked at $770K in Q4 2015.
  • 931 funds tracked by Wall St. Rank held Cardinal Health as of Q4 2022.

Based on Jaffetilchin Investment Partners's 13F filing for Q4 2022, filed 10 Feb 2023.